Source: https://www.koreabiomed.com/news/art...ml?idxno=21165
Korea's mpox caseload increases to 81
기자명 Lee Han-soo Published 2023.05.22 14:11
SNS 기사보내기
The number of mpox cases in Korea increased by six from last Tuesday to Monday, bringing the total number of confirmed cases to 81.
Except for five cases, the 76 cases have been confirmed since April 4, with Korea confirming 34 cases in May alone.
Even though the World Health Organization (WHO) lifted the Public Health Emergency of International Concern (PHEIC) for mpox on May 11 after 10 months, Korean quarantine authorities are keeping the mpox alert level at caution due to the continuous domestic outbreak...
-
Translation Google
Confirmation of 2 additional mpox patients (4.28. Fri.)
Post Date 2023-04-28 Last modified date 2023-04-28 Department in charge Emerging Infectious Disease Response Division Contact 043-719-9130
Confirmation of 2 additional Mpox patients
2 additional patients confirmed, epidemiological investigation in progress, such as risk exposure
- The Korea Centers for Disease Control and Prevention (KCDC) asks for active reporting as the personal information of the person who reports suspected symptoms is being protected.
The Korea Centers for Disease Control and Prevention (Director Ji Young-mi) announced that two additional patients (#41 and #42) had occurred (April 27) after the announcement of the 40th Mpox confirmed patient in Korea.
The residences of the new confirmed patients are 1 in Gyeonggi and 1 in Incheon, and all of them are Koreans. After experiencing suspicious symptoms, 1 case was reported by the person himself/herself to the Korea Centers for Disease Control and Prevention (1339) and 1 case was reported by a medical institution.
The main symptoms of the above patients were rash, fever, etc., and the overall condition was good.
...
https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722415& cg_code=&act=view&nPage=1
------------------------------------------------
Confirmation of 5 additional mpox patients (May 1)
Post Date 2023-05-01 Last modified 2023-05-01 Department in charge Emerging
Infectious Disease Response Division Contact 043-719-9130
Confirmation of 5 additional Mpox patients
- Epidemiologic investigation on 5 suspected domestic cases, risk exposure, etc.
- The Korea Centers for Disease Control and Prevention (KCDC), the personal information of reporters with suspected symptoms is being protected, so active reporting is requested
- Avoid close contact with strangers and suspect symptoms Avoid contact with others if present
The Korea Centers for Disease Control and Prevention (Chairman Ji Young-mi) announced that after the announcement of the 42nd Mpox confirmed patient in Korea, 5 additional patients (#43~#47) have occurred*, bringing the total number of confirmed patients to date to 47. Among them, a total of 41 patients are presumed to be infected in Korea.
* 1 on April 28, 1 on April 29, 3 on April 30
The residences of the newly confirmed patients are 3 in Seoul, 1 in Chungcheongnam-do, and 1 in Busan. All of them are Koreans. After experiencing suspicious symptoms, 4 cases were reported by the person to the Korea Centers for Disease Control and Prevention (1339), and 1 case was reported by a medical institution.
Rash and fever were confirmed as the main symptoms of these patients, and the overall condition was good. All patients had no overseas travel history within 3 weeks of symptom onset, and risk exposure such as close contact was confirmed in Korea. is estimated as
...
https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=722427& cg_code=&act=view&nPage=1Leave a comment:
-
Translation Google
[4.19. Wed. Regular briefing press release] Strengthening MPOx surveillance and prevention
Post Date 2023-04-19 Last modified 2023-04-19 Department in charge Crisis
Communication Team, Central Defense Response Headquarters Contact 043-719-9372
Promote reinforcement of mpox surveillance and prevention
- Presentation of clinical symptoms and epidemiological characteristics of 13 suspected domestically infected patients
- In order to block the spread of infection, production and distribution of prevention rules for high-risk groups and frequently used facilities and reinforcement of on-site inspection and management
- Main Content -
□ Domestic occurrence status
○ From 4. 7 to 4. 18, 13 presumed infected patients occurred in Korea.
○ Confirmation that there is no overseas travel history within 3 weeks before the first symptom onset
○ The patient's residence is 5 in Seoul, 3 in Gyeonggi, 2 in Gyeongnam, 1 in Gyeongbuk, 1 in Daegu, and 1 in Jeonnam.
...
The Korea Centers for Disease Control and Prevention (Chief Ji Young-mi) announced that there were two additional cases after the announcement of the 16th confirmed case of mfox (monkey pox) in Korea on April 18. This brings the total number of Mpox confirmed patients in Korea to 18.
Both of the two additional cases are suspected domestic infections, and the 17th patient is a Korean living in Seoul, and was confirmed after testing with symptoms such as skin lesions and pain. The 18th patient was a Korean living in Gyeonggi-do, and was confirmed after examination with symptoms of skin lesions and fever.
From April 7, when the first suspected domestic infection occurred, to April 18, there were 13 suspected cases of domestic infection with Mfox. Quarantine authorities are conducting detailed epidemiological investigations on their risk factors and infection routes.
The residences of domestic infected patients were 5 in Seoul, 3 in Gyeonggi, 2 in Gyeongnam, 1 in Gyeongbuk, 1 in Daegu, and 1 in Jeonnam. There were 12 Koreans and 1 foreigner.
All 13 confirmed patients were confirmed to have no history of overseas travel within 3 weeks before the first symptom onset, so they are presumed to be domestic infections. Looking at the risk exposure rate, the majority of those who were confirmed to have had close contact with an anonymous person in high-risk facilities within 3 weeks before the onset of symptoms.
...
-------------------------------------------
Confirmation of 2 additional Mpox patients (April 20. Thu)
Write Date 2023-04-20 Last modified 2023-04-20 Department in charge Emerging Infectious Disease Response Division Contact 043-719-9130
Confirmation of 2 additional Mpox patients
- 2 additional confirmed patients without overseas travel history, epidemiological investigation is underway, such as risk exposure
- There is little possibility of infection in swimming pools or general multi-use facilities
- The Korea Centers for Disease Control and Prevention (KCDC) asks for active reporting as the personal information of the person who reports suspected symptoms is being protected.
The Korea Centers for Disease Control and Prevention (Chairman Ji Young-mi) announced that 2 additional patients (#19, #20) have occurred since the 18th Mpox confirmed case in Korea on April 18.
The 19th patient is a Korean living in Gyeonggi-do, and reported to the Korea Centers for Disease Control and Prevention (1339) because of skin lesions. Due to a history of risk exposure within 3 weeks before the first symptom onset, it was determined as a confirmed patient after examination. (April 19) .)
The 20th patient is a Korean living in Chungcheongbuk -do . He had suspected symptoms such as skin lesions, so he contacted the public health center . Judged. (4.20.)
The newly confirmed patients are currently being hospitalized in isolation beds, and their overall condition is good. Both patients had no history of overseas travel within 3 weeks of the first symptom onset, so detailed epidemiological investigations are being conducted on the route of infection and contacts, including risk exposure in Korea.
...
-------------------------------------------------
Confirmation of 10 additional mpox patients (Apr. 24.)
Write Date 2023-04-24 Last modified date 2023-04-25 Department in charge Emerging Infectious Disease Response Division Contact 043-719-9130
Confirmation of 10 additional Mpox patients
- 10 additional patients without overseas travel history confirmed, epidemiological investigation is underway, such as risk exposure
- The Korea Centers for Disease Control and Prevention (KCDC) asks for active reporting as the personal information of the person who reports suspected symptoms is being protected.
The Korea Centers for Disease Control and Prevention (Chairman Ji Young-mi) announced on April 20th that 10 additional cases (#21~#30) have occurred* since the announcement of the 20th Mpox confirmed patient in Korea. (April 24)
* April 21st 4 people, April 22nd 4 people, April 23rd 2 people
The residences of the newly confirmed patients were 6 in Seoul, 3 in Gyeonggi, and 1 in Gyeongbuk, of which 9 were Koreans and 1 was a foreigner.
Looking at the recognition pathway, there were 4 reports from medical institutions, 5 cases of inquiries to the Korea Centers for Disease Control and Prevention (1339), and 1 case of direct visits to public health centers.
The main symptoms of the confirmed patients were skin lesions accompanied by skin pain, and rashes were confirmed in all patients.
The newly confirmed patients are currently being hospitalized in isolation beds, and their overall condition is good.
All 10 patients had no history of overseas travel within 3 weeks of the onset of symptoms, and risk exposure in Korea was confirmed.
...
---------------------------------------------
Confirmation of 1 additional Mfox patient (Tuesday, April 25)
Write Date 2023-04-25 Last modified date 2023-04-25 Department in charge Emerging Infectious Disease Response Division Contact 043-719-9130
Confirmation of 1 additional Mpox patient
- 1 additional patient without overseas travel history confirmed, epidemiological investigation is underway, such as risk exposure
- The Korea Centers for Disease Control and Prevention (KCDC) asks for active reporting as the personal information of the person who reports suspected symptoms is being protected.
The Korea Centers for Disease Control and Prevention (Director Ji Young-mi) announced that one additional patient (#31) occurred on April 24 after the announcement of the 30th Mpox confirmed patient in Korea.
The 31st patient was a Korean living in Gyeongnam, who reported to the Korea Centers for Disease Control and Prevention (1339) due to skin lesions. Due to a history of risk exposure within 3 weeks before the first symptom onset, it was determined as a confirmed patient after examination. (4.24 .)
The patient is currently receiving inpatient treatment in an isolation ward, is in good overall condition, has no history of overseas travel within 3 weeks of the first symptom onset, and has been confirmed to have been exposed to risk in Korea, so epidemiological investigations are being conducted on the route of infection and contacts. .
...
----------------------------------------------
Confirmation of 6 additional Mpox patients (April 27. Thu)
Post Date 2023-04-27 Last modified 2023-04-27 Department in charge Emerging Infectious Disease Response Division Contact 043-719-9130
Confirmation of 6 additional Mpox patients
- 5 patients presumed to be domestically generated, 1 suspected imported patient
- The Korea Centers for Disease Control and Prevention (KCDC) asks for active reporting as the personal information of the person who reports suspected symptoms is being protected.
The Korea Centers for Disease Control and Prevention (Director Ji Young-mi) announced that 6 additional patients (#35~#40) have occurred* since the announcement of the 34th Mpox confirmed patient in Korea.
* 4 on April 26, 2 on April 27
The residences of the new confirmed patients are 3 in Seoul, 1 in Incheon, 1 in Gangwon, and 1 in Daegu. All of them are Koreans, and 4 cases were reported by the person to the Korea Centers for Disease Control and Prevention (1339) after experiencing suspicious symptoms. It was 2 cases.
The main symptoms of the patients were rash, fever, and lymphadenopathy, and the overall condition was said to be good.
5 out of 6 had no history of overseas travel within 3 weeks of symptom onset, and the risk exposure was confirmed in Korea, so it is presumed to be a domestic occurrence. It is estimated by inflow.
...
Leave a comment:
-
Translation Google
Confirmation of the 10th Mfox domestic patient (Apr. 14. Fri.)
Write Date 2023-04-14 Last modified 2023-04-14 Department in charge Emerging Infectious Disease Response Division Contact 043-719-9130
Confirmation of the 10th Mfox patient in Korea
- Active reporting by medical staff and increased voluntary inquiries from symptomatic patients
- An increasing trend of confirmed cases without overseas travel history, epidemiological investigation is underway
The Korea Centers for Disease Control and Prevention (Director Ji Young-mi) announced that the 10th Mpox confirmed patient had occurred in Korea (April 14).
The patient, who lives in Daegu, is a Korean who inquired at the Korea Centers for Disease Control and Prevention (1339) on April 12 that he would like to take an Mpox test. As a result of the genetic test, it was confirmed positive, and it was determined as a confirmed case.
The patient is currently receiving hospitalized treatment in an isolation ward, and is in good overall condition.
The Korea Centers for Disease Control and Prevention (KCDC) has encouraged active reporting of suspected symptoms even if there is low epidemiological relevance, such as no history of overseas travel, since the first case of suspected domestic infection on April 7. He said inquiries are on the rise.
Young-mi Ji, Director of the Korea Centers for Disease Control and Prevention, emphasized, “Thank you for the active reports and inquiries, and the public’s cooperation is most important for the early detection and rapid diagnosis of Mpox-infected patients,” and said, “Consideration and individual We ask that you work together to protect information.
...
https://www.kdca.go.kr/board/board.e...ist_no=722303& cg_code=&act=view&nPage=1
-----------------------------------
Confirmation of 3 additional Mpox domestically infected patients (April 17)
Post date 2023-04-17 Last modified 2023-04-17 Department in charge Emerging
Infectious Disease Response Division Contact 043-719-9130
Confirmation of 3 additional cases of Mpox domestic infection
- 3 additional confirmed domestically infected patients without overseas travel history -
- Guidance on patient characteristics and suspected symptoms for high-risk medical staff for rapid diagnosis -
- Guidelines on prevention rules for facilities used by high-risk groups and strengthened publicity to curb further spread of radio waves -
- All patients are in good condition, none of the contacts showed suspicious symptoms -
The Korea Centers for Disease Control and Prevention (Chairman Ji Young-mi) announced that since the 10th confirmed patient occurred on the morning of last Friday, there have been 3 additional Mpox confirmed patients in Korea. (April 17)
The 11th patient was a Korean living in Seoul. After visiting a medical institution with sore throat and skin lesions, medical staff suspected Mpox infection and reported it to the local public health center on April 14.
The 12th patient is a Korean who lives in Gyeongnam and inquired about a test at the Korea Centers for Disease Control and Prevention (1339) on April 14 due to skin lesions and pain. (4.15.).
The 13th patient is a Korean living in Gyeongnam. During the epidemiological investigation of the 12th patient, close contacts with suspected symptoms such as skin lesions were identified and tested immediately. did
All newly confirmed patients have no history of overseas travel within 3 weeks of the first symptom onset, but domestic risk exposure has been confirmed, so they are presumed to be domestic infections.
5 out of a total of 8 patients who occurred after April 7 used antiviral drugs under the judgment of medical staff, and said that there were no reports of suspicious symptoms among contacts currently under management.
The Korea Centers for Disease Control and Prevention (KCDC) distributes the MPOX diagnosis guide, including characteristics and occurrence trends, such as suspected symptoms, clinical progress, etc., of confirmed patients at home and abroad to medical personnel. Medical personnel treating skin lesions were requested to actively report suspected cases.
In addition, it was announced that it is making every effort to contain further spread by visiting facilities used by high-risk groups and reinforcing publicity, such as information on compliance with infection prevention rules and production and distribution of guidebooks for high-risk groups.
Director Ji Young-mi of the Korea Centers for Disease Control and Prevention said, “If you have any risk factors or suspicious symptoms, such as close contact with a suspected patient, consult the Center for Disease Control and Prevention (1339), and be especially careful about close contact (skin contact) with people you don’t know.” While emphasizing
Mpox is an infectious disease that is mainly transmitted through limited infection routes (skin and sexual contact) and has a low risk of transmission and can be managed.
* ▼ Avoid close contact (skin/sexual contact) with an unknown person, ▼ Take special care not to come into direct contact with others by covering skin lesions with long-sleeved clothes, etc., ▼ Symptoms (skin rash/ulceration, lymphadenopathy, fever, etc.) ), refraining from close contact (skin/sexual contact) with others, ▼compliance with hand washing, etc.
https://www.kdca.go.kr/board/board.e...t=view&nPage=1
----------------------------------------------------
Confirmation of 3 additional mpox patients (Tuesday, April 18)
Post Date 2023-04-18 Last modified 2023-04-18 Department in charge Emerging
Infectious Disease Response Division Contact 043-719-9130
Confirmation of 3 additional Mpox patients
- 3 additional confirmed patients without overseas travel history, epidemiological investigation such as risk exposure is in progress
The Korea Centers for Disease Control and Prevention (Chairman Ji Young-mi) announced today that three additional Mpox confirmed patients (#14, #15, and #16) have occurred in Korea. (April 18)
The 14th patient was a Korean living in Seoul, who reported suspicious symptoms such as skin lesions to the Korea Centers for Disease Control and Prevention (1339), and was classified as a suspected patient due to risk exposure during the incubation period. .
The 15th patient was a foreigner residing in Gyeongbuk. After visiting a medical institution with a skin lesion, the medical staff suspected Mpox infection and reported it to the local public health center.
The 16th patient was a Korean living in Gyeonggi-do. He reported suspicious symptoms such as skin lesions to the Korea Centers for Disease Control and Prevention (1339).
The newly confirmed patients are currently being hospitalized in isolation wards and are in good overall condition. The three patients said they had no overseas travel history within three weeks of the first symptom onset, so detailed epidemiological investigations were being conducted on the route of infection and contacts, such as risk exposure in Korea.
Ji Young-mi, director of the Korea Centers for Disease Control and Prevention, recently said that the number of Mpox patients has increased, but this is due to rapid diagnosis by encouraging medical staff and the public to report. did
...
https://www.kdca.go.kr/board/board.e...t=view&nPage=1Leave a comment:
-
Translation Google
Mfox crisis alert level raised to 'caution'- Post Date 2023-04-13
- Last modified 2023-04-13
- Department in charge Crisis Communication Team, Central Defense Response Headquarters
- Contact 043-719-7792
Mfox crisis alert level raised to ' caution ' - In line with the increase in cases of Mpox patients in Korea , strengthening countermeasures -
9th confirmed case presumed to occur in Korea , epidemiological investigation in progress
The Korea Centers for Disease Control and Prevention (Chairman Ji Young-mi) held a risk assessment meeting at 5:00 pm yesterday as the number of Mpox patients recently increased in Korea, and announced that it would raise the crisis alert level from 'attention' to 'caution' from today.
At the risk assessment meeting, although the global incidence is declining, the outbreak continues to spread in neighboring countries such as Japan and Taiwan, and the situation where the frequency of occurrence is increasing than before, such as the recent occurrence of three confirmed cases within a week in Korea, was comprehensively reviewed. reviewed.
However, due to the nature of the disease spread through close contact (skin contact, sexual contact, etc.) with the confirmed person, the possibility of a large-scale outbreak in the general population is low, most patients recover naturally, and sufficient countermeasures such as treatment and diagnosis are secured. Considering this, the impact on the public health system was evaluated to be limited.
In accordance with the elevation of the crisis alert level, the Korea Centers for Disease Control and Prevention (KCDC) strengthens response measures*, such as upgrading the currently operating Mfox task force (Chief: Director of the Infectious Disease Crisis Response Bureau) to the Central Defense Countermeasure Headquarters (Head: Director of the Korea Centers for Disease Control and Prevention), and local governments are strengthening response measures*. We plan to set up a regional quarantine countermeasure team centered on the outbreak area and adjacent areas.
<Major Countermeasures>
◈ ( Edemiological investigation ) Investigation of additional infected cases through in-depth epidemiological investigation to identify the source of infection
◈ ( Management of patients and contacts ) Monitoring the occurrence of symptoms and strengthening vaccination recommendations for close contacts
◈ ( Education and publicity ) Guidance and training on prevention guidelines centered on medical staff and the LGBTI community , encouragement to report suspected symptoms
◈ ( Diagnosis , Vaccine , and Treatment ) Respond with diagnostic reagents , vaccines , and treatments already secured , but additionally secured if necessary in preparation for an increase in patients
Meanwhile, the Korea Centers for Disease Control and Prevention announced that one additional Mpox confirmed patient was confirmed after the crisis assessment meeting. The 9th confirmed patient is a Korean living in Gyeonggi-do, who visited a medical institution with symptoms of skin lesions on April 12. The medical institution suspected Mpox infection and reported it to the local public health center. Currently, he is hospitalized in isolation and is being treated, and the use of Tecovirimat treatment is also being reviewed.
The patient has no history of overseas travel within 3 weeks before the first symptom onset, and close contact was confirmed in Korea, so it is presumed to be a domestic infection.
Ji Young-mi, head of the Korea Centers for Disease Control and Prevention, said, “The adjustment of this stage is in accordance with the need to take preemptive measures to curb transmission within the community through unconfirmed infected persons.” emphasized the most important.
In addition, medical staff were again asked to wear protective gear when treating suspected patients, to actively monitor and report patients, and to report to the local public health center if symptoms are suspected.
...
Leave a comment:
-
Source: https://www.koreatimes.co.kr/www/nat...19_340360.html
Korea confirms 4th case of monkeypox: KDCA
Korea on Tuesday confirmed its fourth case of monkeypox, health authorities said.
Posted : 2022-11-22 22:15
Updated : 2022-11-22 22:15
The patient is a medical worker of a hospital, where the country's third monkeypox patient was hospitalized for a test, according to the Korea Disease Control and Prevention Agency (KDCA).
The person has been on a high-risk list after being accidentally pricked by an injection needle while taking a skin lesion sample from the patient on Nov. 14...Leave a comment:
-
Source: https://koreajoongangdaily.joins.com...171812519.html
September 4, 2022
Korea reports second confirmed case of monkeypox
Korean health authorities reported the country's second confirmed case of monkeypox over the weekend, raising concerns about the potential spread of another virus amid an ongoing spike in Covid-19 infections.
According to the Korea Disease Control and Prevention Agency (KDCA) on Saturday, the patient is a Korean citizen who arrived at Incheon International Airport from Europe on Aug. 18.
The patient initially visited a small private clinic in Seoul on Aug. 30 after they began experiencing a fever, headaches, dizziness and skin pain two days earlier.
The patient then submitted a report to a local public health center on Thursday, which led the Seoul city health service to order a viral genetic test that confirmed the monkeypox infection on Saturday.
The KDCA transferred the patient the same day to receive treatment in isolation at the National Medical Center. The patient is reported to be in good condition with mild symptoms...Leave a comment:
-
(4th LD) S. Korea confirms 1st case of monkeypox infection
National 19:11 June 22, 2022
...
SEOUL, June 22 (Yonhap) -- South Korea on Wednesday confirmed its first case of monkeypox infection, prompting concerns over the possibility of the spread of the virus.
The Korea Disease Control and Prevention Agency (KDCA) said the patient, who arrived at Incheon International Airport from Germany at 4 p.m. Tuesday, has tested positive for the virus. The person has been in isolation treatment at Incheon Medical Center, west of Seoul, since arriving in South Korea.
The person reportedly had a headache two days before departing and showed symptoms of fever, sore throat, lethargy and skin lesions when arriving in South Korea.
An epidemiology survey showed the person had no high-risk associates, meaning family members or anyone who had regular or sexual contact within 21 days.
KDCA said it was actively monitoring health conditions of those who sat near the patient on the person's arrival flight.
The agency also raised the country's monkeypox risk level from "attention" to "caution" and decided to bolster measures against the spread of the virus.
A foreigner who has been hospitalized in Busan, 450 kilometers southeast of Seoul, after showing possible symptoms of monkeypox has tested negative. The person was found to have chickenpox.
...
https://en.yna.co.kr/view/AEN2022062...ional/national
--------------------------------------------------------------------------------
Translation Google
press release
Infectious disease crisis alert level raised following the first case of monkeypox in Korea
Posted on 2022-06-22 Last modified 2022-06-22 Department in charge New Infectious Disease Response Division Contact 043-719-9130
* Edit page 2 : Deleted countries where monkeypox is common.
Infectious disease crisis alert level raised following the first case of monkeypox in Korea
- Main Content -
□ As a result of the diagnostic test of two patients with monkey pox,one Korean confirmed positive.
* Patient was transferred to Incheon Medical Center and treated, in-depth epidemiological investigation in progress
□ After analyzing and evaluating the crisis situation, the crisis alert level was raised to 'caution', and the Central Quarantine Countermeasures Headquarters was activated.
□ Requesting cooperation from the public and the medical community for early detection and prevention of community spread
* Observe personal hygiene rules and consult with the Center for Disease Control and Prevention if symptoms occur within 21 days of returning to Korea
□ The Korea Centers for Disease Control and Prevention (Chairman Baek Kyung-ran) informed that as a result of diagnostic tests** of two patients with monkey pox, one Korean was confirmed as a final positive.
* One foreigner who entered on June 20, and one Korean who entered on June 21
** Method of amplifying and detecting the specific gene of monkey pox virus
□ This patient is a Korean who returned from Germany around 4:00 pm on June 21st, and started with headache symptoms on June 18th before entering the country. He showed systemic symptoms and skin lesions,
○ After arriving at Incheon International Airport, he reported his suspicion to the Korea Centers for Disease Control and Prevention, and was classified as a doctor patient by the airport quarantine station and the Central Epidemiological Investigator.
□ As the confirmed cases were confirmed, the quarantine authorities held a crisis assessment meeting (chaired by the Deputy Director of the Korea Centers for Disease Control and Prevention) today to analyze and evaluate the crisis situation, and then decided to upgrade the crisis situation from 'interest' to 'caution'.
○ Due to this patient outbreak, the Minister of Health and Welfare and the head of the Korea Centers for Disease Control and Prevention issued a crisis alert level 'caution' according to the 「Standard Manual for Infectious Disease Disaster Crisis Management」.
○ Accordingly, the current countermeasures team (Chief: Director of the Infectious Disease Crisis Response Bureau) will be upgraded to the Central Quarantine Countermeasures Headquarters (Headquarters: Director of the Centers for Disease Control and Prevention) to strengthen the multi-ministerial cooperation system.
- In addition, it was announced that all cities, counties, and gu within the city/province of the country will operate an emergency quarantine system to install and operate local quarantine countermeasures teams.
□ The quarantine authorities have decided to designate a quarantine management area for monkey pox in the second half of the year, and in particular, in countries where monkey pox is common, strengthen the monitoring of foreign inflow by strengthening fever standards.
○ In addition, by strengthening the guidance using the SMS text message and quarantine information pre-entry system (Q-code) for inbound and outbound travelers, the rate of self-reporting of health status questionnaires of inbound travelers will be improved,
- If suspicious symptoms occur within the incubation period after entry, it will continue to be encouraged to report to 1339.
□ Regarding monkeypox vaccination, we plan to make it available to those who wish to be vaccinated in consideration of the risk of contact with the patient to prevent onset and aggravation after exposure.
- In addition, the rapid introduction of a third-generation vaccine is in progress.
□ Distributing and using currently available therapeutic agents in Korea (cidofovir, vaccinia immunoglobulin, for a total of 100 patients) to medical institutions if necessary;
○ Tecovirimat (oral), an antiviral drug for the treatment of monkey pox, is scheduled to be introduced in Korea in July.
* Distribution of the treatment guide (1st edition) (6. 8.)
□ The Korean Center for Disease Control and Prevention (KCDC) plans to conduct diagnostic tests for doctors and patients for the time being, but in the future, considering the situation of monkeypox in Korea, if there is a concern about the spread, the local government plans to expand the test to be performed.
□ The Korea Centers for Disease Control and Prevention has distributed a guide for medical staff to respond to monkey pox, and plans to provide training for patients with suspected monkey pox in front-line medical institutions and provide training to respond to confirmed cases, and distribute videos.
□ In accordance with the WHO International Health Regulations (IHR)*, the quarantine authorities notified the WHO Western Pacific Regional Office and Germany, the country of departure of the confirmed patient, of information on the occurrence of confirmed cases of monkey pox and measures to be taken this afternoon.
* International health rules: International rules established by WHO with member countries for the purpose of preventing, preparing, managing and responding to the spread of public health risks such as large-scale infectious diseases
□ Meanwhile, the Korea Centers for Disease Control and Prevention (KCDC) emphasizes that cooperation between the public and the medical community is more important than anything else for the early detection of monkey pox and blocking the spread of monkey pox in the local community.
○ For citizens visiting or traveling to countries with monkeypox, observe personal hygiene rules such as washing hands and wearing a mask,
- If you develop symptoms within 21 days of returning to your home country, you are advised to contact the Korea Centers for Disease Control and Prevention (KCDC) call center (1339).
○ Medical staff were asked to wear safe protective gear when treating patients with suspected monkey pox, and to actively cooperate in monitoring and reporting patients.
...
https://www.kdca.go.kr/board/board.e...ist_no=719909& act=viewLeave a comment:
-
South Korea - Mpox outbreak 2022 - 2023
(2nd LD) S.Korea reports first two suspected cases of monkeypox
National 09:22 June 22, 2022
...
SEOUL, June 22 (Yonhap) -- South Korea has reported its first two suspected cases of monkeypox, public health officials said Wednesday.
The Korea Disease Control and Prevention Agency (KDCA) said two probable cases were found Tuesday and diagnostic tests are being conducted.
KDCA said one of the suspected patients was a foreigner, who arrived in the country on Monday, and another was South Korean, who arrived on Tuesday.
According to officials, the foreigner visited a hospital in Busan, 450 kilometers southeast of Seoul, on Tuesday after having a sore throat, skin lesions and other possible symptoms of the monkeypox virus and has been admitted there after hospital officials reported it as a possible case.
The South Korean arrived at Incheon International Airport from Germany around 4 p.m. Tuesday and reportedly showed symptoms two days before arriving. The person was admitted to Incheon Medical Center in Incheon, west of Seoul, after arriving.
Both were in isolation treatment at their respective hospitals.
...
https://en.yna.co.kr/view/AEN2022062...ional/national
-------------------------------------------------------------------
Translation Google
Two suspected monkey pox patients, diagnostic test in progress (6.22.)
Posted on 2022-06-22 Last modified 2022-06-22 Department in charge New Infectious Disease Response Division Contact 043-719-9130
Two suspected monkey pox patients, diagnostic test in progress
□ The Korea Centers for Disease Control and Prevention (Chairman Baek Kyung-ran) announced on the afternoon of June 21 that two patients with clinical symptoms of systemic symptoms and skin lesions were reported as 'doctor patients*' with monkey pox and are currently undergoing testing.
* (Terminology) Monkey smallpox 'physician patient': Considering clinical symptoms and epidemiologic relevance, a person who has suspected monkey smallpox but does not have test results that meet the test criteria for diagnosis
○ The first medical patient is a foreigner who entered Korea by air on June 20.
- From June 19th, symptoms of bullous skin lesions occurred along with systemic symptoms such as sore throat and lymphadenopathy. Due to these symptoms, on the morning of June 21st, he was admitted to a hospital in Busan (a nationally designated inpatient treatment bed).
- Dongho Hospital reported a suspected case of monkey pox at 4 pm on the 21st, and is currently undergoing treatment in an isolation ward at the same hospital.
○ The second doctor patient is a Korean who returned from Germany around 4:00 pm on June 21, starting with headache symptoms on June 18 before entry, and at the time of entry, mild fever (37.0℃), sore throat, asthenia (feeling weak), He showed systemic symptoms such as fatigue and skin lesions.
- After arriving at Incheon International Airport, he reported his suspicion to the Korea Centers for Disease Control and Prevention and was classified as a pseudo-patient by the Airport Quarantine Office and Central Epidemiological Investigator.
- After waiting at the airport quarantine facility, he was transferred to Incheon Medical Center (a nationally designated inpatient treatment bed) and is being treated.
□ The quarantine authorities explained that they are currently conducting a diagnostic test and epidemiological investigation of monkey pox, and they said that they plan to hold a briefing as soon as the test results are released to inform about measures and response plans.
...
https://www.kdca.go.kr/board/board.e...ist_no=719902& act=view
Leave a comment: